stomach paralysis semaglutide Reports indicate that the creators of Ozempic (semaglutide) are facing a $2 billion lawsuit after thousands of patients allegedly experienced severe side effects, including: louisiana semaglutide stomach paralysis law

It's only been 20 years since GLP-1 medications got FDA approval for diabetes, and their approval for weight management is even more recent

So while weight loss and side effects matter, many people also start thinking about something more practical: how this medication fits into everyday life

Glucagon-like Peptide 1 Molecule #1 is a photograph by Molekuul / Science Photo Library which was uploaded on September 24th, 2018

Market Restraints Drug Pricing, Supply Constraints, Gastrointestinal Tolerability, and Compounding Disruption Limit GLP-1 Market Scaling Drug pricing and affordability remain the most impactful near-term restraints for the GLP-1 Weight Loss Drug Market through 2030